Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailU.S. doctors are 'wowed' by Novo Nordisk's weight-loss drug data, analyst saysPeter Verdult, managing director of Citi Pharma Research Citigroup, discusses the findings of Novo Nordisk 's closely watched "SELECT" trial.

---

Persons: Peter Verdult Organizations: Novo, Citi Pharma Research Citigroup, Novo Nordisk